Peptide T bolus normalizes the growth hormone secretion pattern in two children with AIDS

Peptides

Volumn 23, Issue 12, 2002, Pages 2279-2281

  Barbey Morel, Charlotte ^a   McDonnell, Kevin ^a   Pert, Candace B ^a   Adams, MerriBeth ^b   Farrand, Dean ^b   Ruff, Michael R ^a   Lumpkin, Michael D ^a  

^a GEORGETOWN UNIVERSITY   (United States)

^b Advanced Immuni T Inc   (United States)

Author keywords

AIDS wasting; gp120; Growth hormone; Growth hormone releasing hormone receptor; HIV envelope protein; Pediatric AIDS; Peptide T

Indexed keywords

PEPTIDE T;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG TARGETING; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HUMAN; HUMAN TISSUE; MEDICAL RESEARCH; PRIORITY JOURNAL; SCHOOL CHILD; TOXICITY; WASTING SYNDROME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ANTI-HIV AGENTS; CHILD; GROWTH HORMONE; HIV; HUMANS; PEPTIDE T; TIME FACTORS;

EID: 0036948169     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(02)00268-1     Document Type: Article

References (9)

1. Arimura A., Somogyvari-Vigh A., Weill C., Fiore R.C., Tatsuno I., Bay V.et al. PACAP functions as a neurotrophic factor. Ann. NY Acad. Sci. 739:1994;228-243.
2. Barrera C.M., Kastin A.J., Banks W.A. D- [Ala1]-peptide T-amide is transported from blood to brain by a saturable system. Brain Res. Bull. 19:1987;629-633.
3. Brenneman D.E., Hauser J., Spong C.Y., Phillips T.M., Pert C.B., Ruff M. VIP and D-ala-peptide T-amide release chemokines which prevent HIV-1 GP120-induced neuronal death. Brain Res. 838:1999;27-36.
4. Bridge et al. Fourth International AIDS Conference, 1989 [Abstract # 3103].
5. Mulroney S.E., McDonnell K.J., Pert C.B., Ruff M.R., Resch Z., Samson W.K.et al. HIV gp120 inhibits the somatotropic axis: a possible GH-releasing hormone receptor mechanism for the pathogenesis of AIDS wasting. Proc. Natl. Acad. Sci. USA. 95:1998;1927-1932.
6. Ratner K.F., Gertner J.M., Sleeper L.A., Donfield S.M. Growth hormone secretion in HIV-positive versus HIV-negative hemophilic males with abnormal growth and pubertal development. The Hemophilia Growth and Development Study. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 15:1997;137-144.
7. Redwine L.S., Rone J.D., Pert C.B., Nixon R., Vance M., Sandler B.et al. GP120(V2)-derived peptide T blocks GP120/CCR5 chemokine receptor mediated chemotaxis. Clin. Immunol. 93:1999;124-131.
8. Ruff M.R., Melendez-Guerrero L.M., Yang Q., Ho W., Mikovits J.W., Pert C.B.et al. Peptide T inhibits HIV-1 infection mediated by the chemokine receptor-5 (CCR5). Antiviral Res. 52:2001;63-75.
9. Schambelan M.K., Mulligan C., Grunfeld E.S., Daar A., LaMarca D.P., Kotler J. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group. Ann. Intern. Med. 125:1996;873-882.